Test Cover Image of:  Nanotechnology Reviews
Impact Factor

Nanotechnology Reviews

Editor In Chief: David Hui

Since January 1st 2019, as the Nanotechnology Reviews journal has been transformed to an Open Access model, there is only one Issue per Volume, and all the published manuscripts are continuously added to the to the same, current Issue in the actual Volume.

Your Benefits

  • Extensive outreach of Nanotechnology Reviews (NTREV) in the academic world
  • Interdisciplinary approach to Nanoscience and Nanotechnology
  • Innovative and pioneering contributions bringing you up to date
  • Critical and exhaustive approach to potential technologies
  • International, authoritative and topnotch editors and reviewers boosting the prestige of published papers

The Nanotechnology Reviews journal aims to promptly provide a forum of scientific information involving all aspects of nano science or nano engineering. The aim is to narrow the gap between pure science and engineering aspects of nanotechnology. The emphasis is on hot or emerging innovative topics of all areas of engineering science at the nanoscale, but in particular, nano-energy, nano-biomaterials, and nano-composites. The journal emphasizes interdisciplinary and multi-functional research and linkage between Nano Technology and Composites Technology. The scope of nanotechnology is expanding everyday. Thus, non-nano papers with potential significant future contributions to nano research may be welcomed on a case by case basis. These topics include, bio-inspired/soft materials, 3D/4D printing, molecular dynamics/multi-scale modeling, imaging, batteries, graphene/carbon nano tubes, nano-mechanics, among many others. The authors are encouraged to discuss the critical unresolved issues on nano-engineered materials, and all research results and conclusions must be substantiated by experiments and mathematical modeling. This journal welcomes both regular and review articles.

Journal partners:

Call for papers for the 28th International Conference on Composites or Nano Engineering, ICCE-28 July 19-25, 2020 in Prague, Czech Republic
Please see the Conference webpage for details:

Journal Metrics

5-year Impact Factor
Cite Score
Impact Factor
SCImago Journal Rank
Scource Normalized Impact per Paper

Abstracting & Indexing

Nanotechnology Reviews is covered by the following services:

  • Baidu Scholar
  • Cabell's Whitelist
  • Case
  • Chemical Abstracts Service (CAS) - CAplus
  • Chemical Abstracts Service (CAS) - SciFinder
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • EBSCO (relevant databases)
  • EBSCO Discovery Service
  • Ei Compendex
  • Engineering Village
  • Genamics JournalSeek
  • Google Scholar
  • Inspec
  • Japan Science and Technology Agency (JST)
  • J-Gate
  • Journal Citation Reports/Science Edition
  • JournalGuide
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • Meta
  • Microsoft Academic
  • MyScienceWork
  • Naver Academic
  • Naviga (Softweco)
  • Norwegian Register for Scientific Journals, Series and Publishers
  • Paperbase
  • Pirabase
  • Polymer Library
  • Primo Central (ExLibris)
  • ProQuest (relevant databases)
  • Publons
  • QOAM (Quality Open Access Market)
  • ReadCube
  • Reaxys
  • SCImago (SJR)
  • Semantic Scholar
  • Sherpa/RoMEO
  • Summon (ProQuest)
  • TDNet
  • TEMA Technik und Management
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • Web of Science - Current Contents/Physical, Chemical and Earth Sciences
  • Web of Science - Science Citation Index Expanded
  • WorldCat (OCLC)


You can easily submit your manuscript online. Simply go to https://www.editorialmanager.com/ntrev and you will be guided through the whole peer reviewing and submission process

Your benefits of publishing with us

  • Easy-to-use online submission, peer review, and publication system
  • Color figure publication free of charge
  • Short turnaround times
  • Every article easily discoverable because of Search Engine Optimization (SEO) and comprehensive abstracting and indexing services
  • High Impact Factor (2018: 2.759)
  • Convenient citation tracking via e-mail alert
  • Secure archiving by De Gruyter and the independent archiving service Portico
  • Professional sales and marketing activities

Submission process

  • Submission of your paper via our submission management tool following the Instructions_for_Authors (you will be guided through every step of the submission process)
  • Single-blind peer review process
  • A decision on your paper is aspired within three weeks

Ethical conduct of research

  • For information on plagiarism, please refer to COPE Committee on Publication Ethics. Any previously published material must be referenced appropriately in the manuscript.
  • Before submitting your article please have a look at NTREV_Publication Ethics Statement and our copyright agreement
  • Informed consent The protection of privacy is a legal right that must not be infringed without individual informed consent. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain full documentation of informed consent, including written permission from the patient or their legal guardians prior to inclusion in the study. The following (or similar) statement should be included in the Materials and methods section: Informed consent was obtained from all individuals included in this study.
  • Authorization for the use of human subjects Manuscripts containing information related to human use should clearly state that the research complies with all relevant national regulations and institutional policies and has been approved by the authors' Institutional Review Board or any equivalent Committee. Copies of the guidelines and policy statements must be available for review by the Managing Editor if necessary. The editors reserve the right to seek additional information or guidance from reviewers on any cases in which concerns arise. All investigations with human subjects must have been conducted by following the tenets of the Declaration of Helsinki, what is more authors must identify the committee or review board approving the experiments, and provide a statement indicating approval of the research. The following (or similar) statement should be included in the Methods section: Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board or equivalent committee.
  • Authorization for the use of experimental animals Manuscripts containing information related to animals use should clearly state that the research has complied with all relevant national regulations and institutional policies and has been approved by the authors' institutional review board or equivalent committee. Copies of the guidelines and policy statements must be available for review by the Managing Editor if necessary. The editors reserve the right to seek additional information or guidance from reviewers on any cases in which concerns arise. The research using animal subjects should be conducted according to the Principles of Laboratory Animal Care and similar documents (e.g. NIH). For manuscripts reporting experiments on live vertebrates or higher invertebrates, authors must identify the committee approving the experiments, and must confirm that all experiments were performed in accordance with relevant regulations. The following (or similar) statement should be included in the Methods section: Ethical approval: The research related to animals use has been complied with all the relevant national regulations and institutional policies for the care and use of animals.
  • If the manuscript does not contain any study that requires human or animal ethical approval, the following statement should be included in the Methods section: Ethical approval: The conducted research is not related to either human or animals use.
  • Conflict of interest and author contributions A conflict of interest for a given manuscript exists when a participant in the peer review and publication process – author, reviewer, and editor – has ties to activities that could inappropriately influence his or her judgment, regardless of whether judgment is, in fact, affected. Financial relationships with industry (for example, employment, consultancies, stock ownership, honoraria, expert testimony), either directly or through immediate family, are usually considered the most important conflicts of interest. However, conflicts can occur for other reasons, such as financial support of the study, ties to health insurance, politics or other stakeholders, personal relationships, academic competition, and intellectual passion. To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest (financial, personal or professional) in connection with the manuscript under evaluation. This must be declared during the submission process and also at the end of the the manuscript. If you have no declaration to make, please insert None declared. The below mentioned statement should be included before the Reference section (or after the Acknowledgments section, if applicable). Authors must also declare responsibility for the entire content of the manuscript and may declare individual contributions of each author, if applicable.

Please note

  • Manuscripts must be written in clear and concise English

We look forward to receiving your manuscript!

David Hui, University of New Orleans, USA; E-mail: dhui@uno.edu

Editorial Board
Alberto Bianco, Immunology, Immunopathology and Therapeutic Chemistry, I2CT, CNRS, France
Katerinqa Chlichlia, Democritus University of Thrace, Alexandroupolis, Greece
Xiaowei Deng, University of Hong Kong
Jitang Fan, Beijing Institute of Technology, China
Mizi Fan, Brunel University, UK
Daining Fang, Beijing Univ.Tech., China
Jiyang Fu, Guangzhou University, China
Milan Gaff, Czech University of Life Sciences Prague
Lizeng Gao, Institute of Biophysics, Beijing, China
Wei Gao, University of New South Wales, Australia
Michal M. Godlewski, Warsaw University of Life Sciences, Poland
Linxia Gu, Florida Institute of Technology, USA
Hamdi Bin Abd Shukor, Universiti Kebangsaan Malaysia
Weidong He, UESTC, Chengdu, China
Soon Hyung Hong, KAIST, South Korea
Xian Jian, UESTC, Chengdu, China
Denvid Lau, City University, Hong Kong
Jinyang Li, Southwest Jiaotong University, China
Haibao Lv, Harbin Institute of Technology, China
Fanbin Meng, Southwest Jiaotong University, China
K.Y. Rhee, Kyung Hee University , Yongin, S. Korea
Jong Il Song, Changwon Nat. U., S. Korea
K.X. Song, Henan University of Science and Technology, Luoyang, China
Mohammad Talha, Indian Inst.Tech., Mandi
C.P. Tsui, Hong Kong Polytechnic University
Guannan Wang, Zhejiang University, China
Nan Wu, University of Manitoba, Canada
Feng Xing, Shenzhen Univ., China
Yumin Yang, Nantong University, Jiangsu, China
Chunwei Zhang, Qingdao University of Technology, China
He Zhang, Zhejiang University, Hangzhou, China
Changchun Zhou, Sichuan University, China
Zuowan Zhou, Southwest Jiaotong University, China
Jackie Yi-Ru Ying, NanoBio Laboratory, Singapore

Advisory Board
Aurelio L. Araujo, University of Lisbon, Portugal
Philippe Boisse, University of Lyon, France
Monssef Drissi-Habti, IFSTTAR, Nantes, France
Viktor Gribniak, VGTU, Vilnius, Lithuania
A.H. Sofiyev, Suleyman Demirel University, Isparta, Turkey
Lubomir Lapcik, Tomas Bata University in Zlin, Czech Rep.
Ahmad Mujahid Ahmad Zaidi NDUM, Kuala Lumpur, Malaysia
Theodoros C. Rousakis, D.U.Th., Xanthi, Greece
Kun Zhang, Donghua University, Shanghai, China
Jianren Zhou, Prairie View A&M University, Texas, USA

De Gruyter Poland Ltd.
Bogumiła Zuga 32A
01-811 Warsaw / Poland
Tel: +48 22 701 50 15

Editorial Office
Juliusz Skoryna, Ph.D., Eng.
Managing Editor
Email: Juliusz.Skoryna@degruyter.com